SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Analysis shows 90 per cent of CBD brands third-party test products

    By

    A new analysis of CBD product testing has shown that 90 per cent of brands third-party test their products.

    With the growing number of CBD products available in stores across Europe and the US, there are concerns among consumers regarding regulatory oversight. A new analysis by industry watchdog, CBD Oracle, has demonstrated that of 520 companies and 20,000 products in Europe and the US 90 per cent of brands carry out third party testing.

    The analysis also shows an increase in certified-USDA organic companies, indicating a higher level of self-regulation in an unregulated industry.

    Alisdair Mans Cornwell, senior editor at CBD Oracle, commented: ”Despite consumer apprehension being a huge problem, our analysis suggests an industry so conscious of its regulatory shortcomings; it’s taking appropriate steps to fix them.”

    “Testing evaluates CBD and THC levels, as well as the presence of pesticides, heavy metals, and solvents. 90% of CBD companies conduct independent, third-party testing on their products and publish all-important Certificates of Analysis as proof. 25 companies are also certified USDA Organic, up by 24 since 2019.

    “Third-party testing and USDA certifications aren’t required by law. It’s great to see companies taking the initiative to legitimise the industry, instill confidence in consumers, and ensure product safety and transparency despite the clear lack of federal oversight.”

    The analysis highlights, however, that celebrity-owned brands and companies selling CBD drinks are the least transparent, noting that Mike Tyson’s Dwiink brand and Ivan Moody’s Moody’s Medicinals fail to provide extraction method, hemp source, or third-party testing information.

    Likewise, the majority of companies specialsing in CBD drinks and beverages don’t disclose their extraction methods or third-party testing.

    “The CBD industry certainly isn’t in the clear yet, but this analysis shows it’s doing way better than most expected,” Alisdair concludes.

    View full report: https://cbdoracle.com/cbd/cbd-companies-list/

    [activecampaign form=31]

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free